Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb45f324cc677e189ceec8580dcebf86 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
filingDate |
2007-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0b8b3773c57a392b4595398a9621f5d |
publicationDate |
2008-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2008020982-A1 |
titleOfInvention |
Methods and compositions for treatment of atherosclerosis |
abstract |
The present invention provides methods and compositions for treating subject having atherosclerosis. The invention provides a method comprising administering to a subject having atherosclerosis an effective amount of insulin like growth factor-1 (IGF-1), wherein the administering is effective to treat atherosclerosis in the subject. The invention also provides kits for practicing the methods of the invention. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2010225460-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010105302-A1 |
priorityDate |
2006-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |